Company: EUDAW
Filing Date: 2025-09-24
Form Type: 20-F/A
Source: 0001493152-25-014808
Chunk: 39

Company: EUDA Health Holdings Ltd
Filing Date: 2025-09-24
Form: 20-F/A
Chunk 39
---
 December 31, 2023, reflect that EUDA has achieved both of the following financial metrics for such fiscal year:     
 (x) revenues of at least $20,100,000 and (y) net income attributable to EUDA of at least $3,600,000.                                   |
| ○ | 1,000,000                                                                                                                              
 additional Earnout Shares to be issued if the consolidated audited financial statements of EUDA for the fiscal year commencing January 
 1, 2024 and ending December 31, 2024, reflect that EUDA has achieved both of the following financial metrics for such fiscal year:     
 (x) revenues of at least $40,100,000 and (y) net income attributable to EUDA of at least $10,100,000.                                  |

In connection with the closing the Business Combination:

| ● | all                                                                                                                  
 8i’s no par value public ordinary shares of 2,591,545, net of the redemption of 6,033,455 shares of Company’s no par 
 value ordinary shares, remained outstanding;                                                                         |
| ● | all                                                                                                                  
 8i’s no par value private ordinary shares of 292,250 remained outstanding;                                           |
| ● | all                                                                                                                  
 8i’s no par value founder shares of 2,156,250 remained outstanding;                                                  |

| ● | all                                                                                                                                   
 8i’s rights, consisting of 8,625,000 public rights and 292,250 private rights, automatically converted into an aggregate of           
 891,725 of the Company’s no par value ordinary shares;                                                                                |
| ● | 200,000                                                                                                                               
 shares of the Company’s no par value ordinary shares were issued to a service provider in connection with the business combination;   |
| ● | 60,000                                                                                                                                
 shares of the Company’s no par value ordinary shares were issued to a service provider in connection with the closing of transactions 
 contemplated pursuant to certain share purchase agreement. Such issuance of the ordinary share serves the purpose of securing the     
 repayment of $300,000 convertible promissory note to the service provider;                                                            |

| F-24 |

EUDA HEALTH HOLDINGS LIMITED AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(In U.S. dollars, unless stated otherwise)

The following table presents the number of the Company’s ordinary shares issued and outstanding immediately following the Reverse Recapitalization:

Schedule of shares issued